1. Home
  2. RR vs INDP Comparison

RR vs INDP Comparison

Compare RR & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

SELL

Current Price

$1.47

Market Cap

375.9M

Sector

N/A

ML Signal

SELL

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

SELL

Current Price

$2.45

Market Cap

438.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RR
INDP
Founded
2016
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
375.9M
438.4M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
RR
INDP
Price
$1.47
$2.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 3.7M
657.6K
Earning Date
08-19-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $5,045,000.00
N/A
Revenue This Year
$8.03
N/A
Revenue Next Year
$22.75
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 18.99
N/A
52 Week Low
$1.30
$0.92
52 Week High
$7.00
$5.96

Technical Indicators

Market Signals
Indicator
RR
INDP
Relative Strength Index (RSI) 38.13 48.74
Support Level $1.30 $2.30
Resistance Level $1.79 $2.96
Average True Range (ATR) 0.08 0.36
MACD -0.02 -0.11
Stochastic Oscillator 4.84 19.61

Price Performance

Historical Comparison
RR
INDP

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: